Tumor Type-Agnostic Treatment and the Future of Cancer Therapy

This publication has 28 references indexed in Scilit:

• TRK Inhibition: A New Tumor-Agnostic Treatment Strategy
  Targeted Oncology, 2018
• Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
  New England Journal of Medicine, 2018
• Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
  Science, 2017
• Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
  Nature Medicine, 2017
• The TPM3‐NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition
  Molecular Oncology, 2014
• Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
  Journal of Clinical Oncology, 2014
• Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer
  Lung Cancer, 2012
• Clinical Relevance of Microsatellite Instability in Colorectal Cancer
  Journal of Clinical Oncology, 2010
• Trk Receptor Expression and Inhibition in Neuroblastomas
  Clinical Cancer Research, 2009
• Comparison of the Microsatellite Instability Analysis System and the Bethesda Panel for the Determination of Microsatellite Instability in Colorectal Cancers
  The Journal of Molecular Diagnostics, 2006